dc.contributor.author | Consejo Ejecutivo, 98 | |
dc.coverage.spatial | Ginebra | en_US |
dc.date.accessioned | 2015-11-10T20:07:30Z | |
dc.date.available | 2015-11-10T20:07:30Z | |
dc.date.issued | 1996 | |
dc.identifier.govdoc | EB98/2 | |
dc.identifier.govdoc | EB98/2 Rev.1 | |
dc.identifier.uri | https://iris.who.int/handle/10665/193805 | |
dc.description | Punto 5 del orden del día provisional. | en_US |
dc.language.iso | es | en_US |
dc.publisher | Organización Mundial de la Salud | en_US |
dc.subject.mesh | Hypertension | en_US |
dc.subject.mesh | Risk Factors | en_US |
dc.subject.mesh | Food Additives | en_US |
dc.subject.mesh | Food Safety | en_US |
dc.subject.mesh | Pharmaceutical Services | en_US |
dc.subject.mesh | Drug Industry | en_US |
dc.subject.mesh | Drug and Narcotic Control | en_US |
dc.subject.mesh | Legislation, Drug | en_US |
dc.subject.mesh | Nursing Services | en_US |
dc.subject.mesh | Nursing, Practical | en_US |
dc.subject.mesh | Primary Health Care | en_US |
dc.subject.mesh | Community Health Services | en_US |
dc.subject.mesh | Delivery of Health Care, Integrated | en_US |
dc.title | Informe sobre reuniones de comités de expertos y grupos de estudio: informe del Director General | en_US |
dc.type | Governing body documents | en_US |
dc.subject.meshqualifier | standards | en_US |
dc.subject.meshqualifier | organization and administration | en_US |